Human Health

What we believe:

Knowledge is power

You can make better choices for managing your health when you gain a basic understanding of the pros and cons of treatment options. We believe that simple, inexpensive options are often the best – but may be neglected or overlooked by researchers, pharmaceutical companies and care providers because of a lack of profit potential and investment.

Our goal:

Improving health with affordable and accessible options

The Parsemus Foundation’s goal is to advance innovative and neglected medical research. We focus on supporting small proof-of-concept studies and then pursuing press coverage of the results, so that the advances change treatment practice rather than disappearing into the scientific literature. Many of the studies we support involve low-cost approaches that are not under patent. From support for new male contraceptives to research on the use of existing medicines to treat COVID-19, the Parsemus Foundation aims to improve human health with affordable and accessible options.

This section of our website provides information on specific medical topics, and includes references and educational links for further study. You’ll also find information on select past projects focused on areas we are no longer pursuing.

Human Health Projects

Iron Deficiency

Iron deficiency and anemia are common and can result in significant negative health impacts. Intravenous iron offers a rapid treatment option.

Read More
breast cancer prevention

Breast Cancer Prevention

Intraductal methods can provide less invasive options for treatment of ductal carcinoma in situ (DCIS), the most common noninvasive lesion of the breast.

Read More
Fluvoxamine and COVID-19 virus

COVID-19

Simple, inexpensive therapies using existing medicines – like measles vaccine and metformin – are being studied to prevent or treat COVID-19 infection.

Read More

Human Health News

Nanotechnology targets cancer through breast ducts

Breast cancer remains a significant health challenge worldwide. While advancements in treatment have improved survival rates, the search for more targeted and effective therapies continues. Nanotechnology-based intraductal drug delivery aims to revolutionize local treatment and prevention of breast cancer by delivering nanocarriers with therapeutic agents directly to the site of the disease.

Read More

Vision loss and dementia risk

A recent study found that up to 19% of dementia cases may be attributable to impaired vision. The study, published in JAMA Ophthalmology, showed that vision loss may have even more of an impact on the risk of dementia than previously thought. Hearing loss is also considered a modifiable risk factor for dementia, supporting the notion that sensory engagement is critical for brain health.

Read More

Blood tests predict cardiovascular disease

Cardiovascular disease is the leading cause of death worldwide. Heart attacks, strokes, and other heart-related conditions claim millions of lives each year — more than cancer. In the U.S., cardiovascular disease kills someone every 33 seconds, and is responsible for more than 20% of all deaths, according to the Centers for Disease Control. But what if a simple blood test could help predict heart disease decades in advance?

Read More

Melatonin shows promise for Alzheimer’s treatment

Recent research has spotlighted melatonin as a potential ally in the fight against Alzheimer’s disease. Scientists from Zhejiang University and Uppsala University published a comprehensive review in the journal Molecular Psychiatry in August 2024, exploring how this natural hormone might protect brain health.

Read More
swimming sperm image

Study highlights growing demand for male contraceptives

A groundbreaking study reveals a strong demand for new male contraceptives worldwide. Researchers surveyed over 18,000 men and 9,000 women across seven countries, uncovering widespread interest in male birth control options. The findings suggest male contraceptives could transform family planning and promote gender equity in reproductive health.

Read More

Nanotechnology targets cancer through breast ducts

Breast cancer remains a significant health challenge worldwide. While advancements in treatment have improved survival rates, the search for more targeted and effective therapies continues. Nanotechnology-based intraductal drug delivery aims to revolutionize local treatment and prevention of breast cancer by delivering nanocarriers with therapeutic agents directly to the site of the disease.

Read More

Vision loss and dementia risk

A recent study found that up to 19% of dementia cases may be attributable to impaired vision. The study, published in JAMA Ophthalmology, showed that vision loss may have even more of an impact on the risk of dementia than previously thought. Hearing loss is also considered a modifiable risk factor for dementia, supporting the notion that sensory engagement is critical for brain health.

Read More

Blood tests predict cardiovascular disease

Cardiovascular disease is the leading cause of death worldwide. Heart attacks, strokes, and other heart-related conditions claim millions of lives each year — more than cancer. In the U.S., cardiovascular disease kills someone every 33 seconds, and is responsible for more than 20% of all deaths, according to the Centers for Disease Control. But what if a simple blood test could help predict heart disease decades in advance?

Read More
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today